copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer
(Any information to deal,buy, sell, quote for products or service)
Terray Therapeutics aims for the clinic by 2026 When Terray Therapeutics launched in 2022, brothers Jacob and Eli Berlin told C EN that the firm was mapping the interactions between small molecules and drug targets
Terray Therapeutics Achieves AI-Enabled Drug Discovery . . . - BioSpace Terray is a chemistry-first, AI-native biotechnology company founded at the convergence point of machine intelligence, human intellect, and medicine The company continues to grow its own dataset, refine its own hardware, and train its own AI to turn impossible drug discovery challenges into inevitable small-molecule solutions
Terray assembles $120M series B to push AI-powered small molecules into . . . Terray Therapeutics has raked in $120 million for a series B fundraise as the AI-focused biotech aims to transform small molecule drug development New investor Bedford Ridge Capital and existing investor NVentures—NVIDIA’s VC arm—led the funding round, which was double the size of Terray’s series A, according to an Oct 17 release
Platform - Terray Therapeutics We experiment beyond limits to design smarter Our experimental platform is built for generative AI-driven drug discovery, integrating chemical experimentation and computation on an unprecedented scale We explore molecules and targets more broadly and deeply with a sophisticated combination of ultra-high throughput experimentation, generative AI, biology, medicinal chemistry, automation, and